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Conclusion: LHA tends to accept EU requirements as much as it 
could match local regulation, but local regulation differs significantly 
from EU. As a consequence, LSU makes additional efforts and com-
munications with LHA and Company, to fulfill each requirement 
in its own way. The differences could be overcome with harmo-
nization of local regulation with EU and if LHA receive access to 
EudraVigilance database.
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Introduction: Medical and pharmaceutical professionals in Serbia 
gather information on drugs from the National Agency of Drugs 
and Medical Devices or from the various publications such as British 
National Fromulary and Physicians Drug Reference. General pop-
ulation can obtain information from their general practitioners 
(GP) or pharmacist. At Department of Pharmacology and Clinical 
Pharmacology, Medical faculty of Novi Sad, there exists a Drug 
Information Unit, regional center offering drug information to both 
professional and general population in Vojvodina (~1,600,000 inhab-
itants).
Patients (or Materials) and Methods: Clients require information 
by telephone (> 99.5% request) or by e-mail. Interns in Clinical 
Pharmacology collect necessary data regarding the therapeutic 
problem (eg, age and sex of the patient, other drugs taken, present 
diseases). After case solving, and upon the approval from the senior 
clinical pharmacologist, interns deliver the information to the client 
(both by telephone and e-mail).
Results: About 3% of all requests are from general population (usu-
ally questions on interactions, side effects, dosing, and administra-
tion). Remaining requests are from health (20% from GPs and 80% 
from specialists) or pharmaceutical professionals. Almost 30% of all 
of the requests of the health professional are regarding possible drug–
drug or drug–disease interactions. About 12% of requests are related 
to side effects of the administered drug. Pregnancy and lactation are 
subjects of interest in 15% of overall number of requests. Maximal 
doses allowed and posology have shares of ~11%. Remaining infor-
mation is concerning the pharmacokinetics of the drug, first-line 
drugs for certain disease, dosing in children, etc.
Conclusion: According to our experience, the Drug Information 
Unit is quite useful source of information for both professionals and 
general population offering various information on different topics 
related to drugs.
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Introduction: Our study assessed the safety of low doses of metha-
done combined with benzodiazepines during first month of metha-
done maintenance treatment (MMT) in opioid addicts, according to 
differences in corrected QT (QTc) interval and side effects.
Patients (or Materials) and Methods: The study included patients 
with a diagnosis of opioid dependence, who were referred to the 
MMT at the Clinic of Psychiatry, Clinical Centre of Vojvodina, Novi 
Sad, during 2012. All patients were interviewed about their age, 
duration of heroin misuse, and the presence of ECG disorders in the 
first-degree relatives. One month after the beginning of MMT, they 
were interviewed about experienced side effects. Data about applied 
methadone dose and the use of benzodiazepines were collected from 
the medical history of each patient. Before the methadone intake for 
the first time and 1 month after the beginning of MMT, all patients 
underwent a 12-lead ECG. The QTc was calculated using Bazett’s 
formula.
Results: A total of 20 patients were enrolled in the study during the 
observed period. Their average age (SD) was 32.21 (5.63) years. 
The average heroin misuse time (SD) was 11.95 (4.02) years. In the 
patients’ history, no cardiovascular diseases were reported, as well as 
sudden cardiac death or family history of long QTc in the first-degree 
relatives. A statistically significant increase (P < 0.05) in the length 
of QTc intervals measured after 1 month of MMT (QTc1) in com-
parison with those at the baseline (QTc0) was observed. The mean 
(SD) methadone dose was 45.26 (15.41) mg. The most frequently 
used drug in combination with methadone was diazepam, which 
was used in 85% of patients. The mean dose (SD) of diazepam was 
30.93 (10.36) mg. A statistically significant dose-dependent correla-
tion between concomitantly used diazepam daily dose and QTc1 
(R2 = 0.47, P = 0.008) was revealed, but without a statistically sig-
nificant dose-dependent correlation between methadone and QTc1 
(P = 0.960). The most commonly reported side effects were sweating 
(65%), obstipation (60%), and itch (55%). None of participants 
experienced any cardiac side effects.
Conclusion: With respect to the results, it would be advisable to 
perform both pretreatment and regular ECG checkup after 1 month 
of MMT, especially in case of concomitant use of benzodiazepines.
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Introduction: According to the recommendations of the World 
Health Organization, ergot alkaloids are neither the drug of first 
choice for the induction of the labor and not for the treatment of the 
postpartum hemorrhage because of their harmful side effects. The 
objective of this research was to follow the influence of the educa-
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tional and administrative measures on the trend of use of uterotonics 
during delivery and puerperium. The study was conducted in the city 
of Novi Sad (350,000 inhabitants), Serbia, in 2012. The results were 
compared with the earlier data.1
Patients (or Materials) and Methods: All women giving the birth at 
Clinic of Gynecology and Obstetrics in Novi Sad during a 1- month 
period in 1988, 1999, 2007, and 2012 were included. Data about 
use of uterotonics during delivery and puerperium were recorded.
Results: The usage of ergot alkaloids for the induction of labor in 
1988 decreased from 54.7% in 1988 to 27% in 1999 after the train-
ing of doctors about the harmful effects of ergot alkaloids. Significant 
changes did not occur in 2007 (26.7%). After the decision of the 
Management of the Clinic of Gynecology and Obstetrics to decrease 
the use of ergot alkaloids for this indication, the reduction was 
recorded at 0.5% in 2012. At the same time, the use of oxytocin 
increased from 62.2% in 1988 to 93.5% in 2012. The use of ergot 
alkaloids for the prevention of the postpartum hemorrhage after the 
educational efforts decreased from 96.8% in 1988 to 9% in 1999. 
During the next 8 years, till 2007, it increased to 69.5% but after 
the the administrative measures, it was almost completely ceased to 
2.8% in 2012. The use of oxytocin decreased after the educational 
measures, whereas the administrative measures did not bring about 
any significant reduction for this indication.
Conclusion: Our results show the reduced usage of ergot alkaloids 
in the induction of labor, as well as in the treatment of postpartum 
hemorrhage as a result of educational and administrative measures. 
These findings are in accordance to the recommendations of the 
World Health Organization.
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Introduction: The appreciation of individual differences in the 
response to pharmacologic treatment has resulted in both exten-
sive research on various reasons for therapy failure and side effects, 
and in the introduction of therapeutic drug monitoring (TDM). The 
establishment of therapeutic levels requires large materials, and reli-
able information about exposure and symptoms. Similarly, making 
the diagnosis fatal drug intoxication as a cause of death remains a 
challenge for toxicologists and pathologists
Patients (or Materials) and Methods: In Sweden, nationwide data-
bases for forensic pathology and forensic toxicology have been in use 
since 1991. We have applied a strategy to select, review, and clas-
sify fatal intoxications and postmortem controls. This project also 
includes the compilation of analytical results obtained from driving 
under the influence cases, TDM cases, and from nonfatal intoxica-
tions. The situation is the same concerning these areas. There is cur-
rently no existing database, where such data are generally accessible 
and searchable.
Results: This strategy resulted in the publication of reference con-
centrations of 83 drugs in postmortem femoral blood. We have 
published an additional compilation focusing on antidepressant 
drugs, in which also relative toxicity index for the drugs studied are 
reported. We are currently reviewing additional groups of drugs 
according to the same protocol. An Internet database (Toxicolist) is 
already running, but it is not as yet made available for other users, 
since we still need to add data about additional drugs to make it 
interesting to wider groups. The database will offer search options 
so that each user can apply a search profile matching, for example, 
a case displaying particular circumstances and findings. At present, 
the database contains the results from > 15,000 postmortem cases, 
and several thousands of drugged driver cases as well as TDM results 
from patients.
Conclusion: Reference concentrations of blood drug levels are 
equally important as e.g. reference levels for various clinical chemis-
try tests of endogenous compounds. This information will improve 
the interpretation of forensic and clinical toxicology results, with 
impact on both medicolegal investigations and on death statistics. 
The levels in the TDM material are also important, particularly for 
a fair idea of whether a certain concentration is apparently elevated 
or implies therapeutic failure. The compilation of results will also 
allow for establishment of relative toxicity index for groups of drugs, 
for example, by comparing fatal and nonfatal intoxications with the 
number of detections and/or sales data. Such information can add 
to our knowledge view of the pharmaceutical profile of the drugs 
in question.
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Introduction: Yarrow (Achillea millefolium) means thousands leaves 
plant and belongs to the Asteraceae family. Yarrow is a gramineous 
perennial plant that grows in mountainous regions of Europe, North 
Africa, and East Asia (including North Iran and Alborz heights). This 
plant has many health benefits like treatingproblems of digestive 
system, respiratory system, cardiovascular system (stimulating blood 
circulation and lowering blood pressure), and genital-urinary system.
Patients (or Materials) and Methods: In this study, the effect of 
Yarrow extract was evaluated on immunity parameters of blood 
serum in little female laboratory rats (Balb/C race).At first, samples 
were divided randomly in 5 groups: 3 treatment groups, 1 control 
group, and 1 placebo group. Each group had 8 members, and all 
groups were kept in similar conditions. Hydroalcoholic extract 
was prepared in 3 doses including 50, 100, and 200 mg/kg and was 
injected in peritoneum every 2 days for 20 days. Normal saline was 
injected to placebo group. All measurements were done using protein 
electrophoresis method. Measured parameters were albumin amount, 
α -1 and α -2 globulin, β globulin, gamma globulin, albumin globulin 
ratio, and total protein.
Results: Results showed that the amount of albumin, β globulin, and 
total protein were increased in all 3 doses. α -2 were decreased in all 
treatments and α -1 were increased in all 3 doses but this increase 
was significant for doses 100 and 200 mg. Albumin globulin ratio 
was increased also in all treatments, but it was significant only for 
50 mg. Gamma globulin amount was increased in 50 and 100 mg 
but decreased a little in 200 mg.
